Wandong Medical has just bought a 22% stake in Yu melting, followed or confronted with some "small problems."
Wandong Medical announced on the evening of July 16 that Chairman Wu Guangming received the “Notice of Investigation†from the China Securities Regulatory Commission on July 13, and the China Securities Regulatory Commission decided to investigate the case for suspected insider trading. The investigation of the case was directed at Wu Guangming's personal special investigation, and the daily production and operation activities of the company were not affected.
And three months ago, Mei Nian Health Chairman Yu Rongcai bought a 22% stake in Wandong Medical.
According to the announcement, on April 10, Wandong Medical's controlling shareholder Yuyue Technology signed a “Share Transfer Agreement†with Mr. Yu Rong, the actual health controller of the US, and Mr. Yu Rong increased his holdings by self-raised funds through agreement transfer. East Medical has 84.99 million shares, accounting for 22% of Wandong Medical's total share capital.
Prior to the transfer, Yuyue Technology held a 46.7% stake in Wandong Medical and held 24.7% of the shares after the transfer.
After the transaction, Wandong Medical has a greater voice in the field of imaging, relying on the quality channel of the United States.
At that time, Midyear Health did not use the cash of listed companies to acquire Wandong Medical, and 22% of the shares were personal investment behavior.
It is worth noting that in this transaction, Yu Rong accepted the equity price of Wandong Medical as 19.5 yuan/share, and the consideration was paid in cash, with a total price of 1.657 billion yuan. The full price was settled before January 31, 2018. .
Yu Rong, who has a high capital operation, has not benefited from the investment of Wandong Medical.
The reporter found that shortly after Yu Rong took over, Wandong Medical announced the high transfer plan at the shareholders' meeting and officially implemented it on May 25.
After the high transfer plan, 22% of the shares bought by Yu Rong were calculated based on the stock price closed on the 14th. The market value was about 1.53 billion yuan, which was still a loss compared with the 1.657 billion yuan bought. 2.7 billion yuan.
Kelp is rich in nutritions and multipl minerals.It make people full but diets. It is the most favorite choice of people with hypertension, hyperlipemia, hyperglycemia.
Extract from the natural plant of Laminaria Japonica which is light grey powder after the special extract processing.They are powder form with good color. It's mainly used for Medicine, cosmetic, food additive field as raw materials.It's very good for human health.
Kelp has anti-can-cer and anti-virus properties related to its antioxidant content and its ability to stimulate your immune system
Kelp Alginate Oligosaccharide,Alginate Oligosaccharide,Seaweed Extract,Kelp Extract For Plants
Shandong Haizhibao Ocean Science and Technology Co.,Ltd. , https://www.haizhibaoseafood.com